{"count": 16, "results": [{"_id": "38568468", "pmid": 38568468, "title": "Metformin: Past, Present, and Future.", "journal": "Curr Diab Rep", "authors": ["Chaudhary S", "Kulkarni A"], "date": "2024-04-03T00:00:00Z", "doi": "10.1007/s11892-024-01539-1", "meta_date_publication": "2024 Apr 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.773, "text_hl": "Prolonged usage of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may lead to @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal discomfort@@@, @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@deficiency of Vitamin B12@@@, or @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@. ", "citations": {"NLM": "Chaudhary S, Kulkarni A. Metformin: Past, Present, and Future. Curr Diab Rep. 2024 Apr 3;():. PMID: 38568468", "BibTeX": "@article{38568468, title={Metformin: Past, Present, and Future.}, author={Chaudhary S and Kulkarni A}, journal={Curr Diab Rep}}"}}, {"_id": "33031284", "pmid": 33031284, "pmcid": "PMC7544303", "title": "Osmolar-gap in the setting of metformin-associated lactic acidosis", "journal": "Medicine (Baltimore)", "authors": ["Elshafei MN", "Alamin M", "Mohamed MFH"], "date": "2020-10-09T00:00:00Z", "doi": "10.1097/MD.0000000000022492", "meta_date_publication": "2020 Oct 9", "meta_volume": "99", "meta_issue": "41", "meta_pages": "e22492", "score": 50251.46, "text_hl": "Forty-five years' old @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetic@@@ @SPECIES_9606 @@@patient@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ presented to emergency with a two-day history of @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, watery @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and mild @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal discomfort@@@. ", "citations": {"NLM": "Elshafei MN, Alamin M, Mohamed MFH. Osmolar-gap in the setting of metformin-associated lactic acidosis Medicine (Baltimore). 2020 Oct 9;99(41):e22492. PMID: 33031284", "BibTeX": "@article{33031284, title={Osmolar-gap in the setting of metformin-associated lactic acidosis}, author={Elshafei MN and Alamin M and Mohamed MFH}, journal={Medicine (Baltimore)}, volume={99}, number={41}, pages={e22492}}"}}, {"_id": "37812890", "pmid": 37812890, "title": "Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet).", "journal": "Biomed Pharmacother", "authors": ["Nabrdalik K", "Drożdż K", "Kwiendacz H", "Skonieczna-Żydecka K", "Łoniewski I", "Kaczmarczyk M", "Wijata AM", "Nalepa J", "Holleman F", "Nieuwdorp M", "Gumprecht J"], "date": "2023-10-07T00:00:00Z", "doi": "10.1016/j.biopha.2023.115650", "meta_date_publication": "2023 Oct 7", "meta_volume": "168", "meta_issue": "", "meta_pages": "115650", "score": 50246.895, "text_hl": "Regardless of the treatment arm allocation, while on probiotic supplementation, there was a significant reduction of incidence (for the probiotic period in PRO-PLA/@CHEMICAL_poly(lactide) @CHEMICAL_MESH:C033616 @@@PLA@@@-PRO: P = 0.017/P = 0.054), quantity and severity of @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@ (P = 0.016/P = 0.024), frequency (P = 0.009/P = 0.015) and severity (P = 0.019/P = 0.005) of @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal bloating@@@/@DISEASE_Pain @DISEASE_MESH:D010146 @@@pain@@@ as well as significant improvement in self-assessed tolerability of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (P < 0.01/P = 0.005). ", "citations": {"NLM": "Nabrdalik K, Drożdż K, Kwiendacz H, Skonieczna-Żydecka K, Łoniewski I, Kaczmarczyk M, Wijata AM, Nalepa J, Holleman F, Nieuwdorp M, Gumprecht J. Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet). Biomed Pharmacother. 2023 Oct 7;168():115650. PMID: 37812890", "BibTeX": "@article{37812890, title={Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet).}, author={Nabrdalik K and Drożdż K and Kwiendacz H and Skonieczna-Żydecka K and Łoniewski I and Kaczmarczyk M and Wijata AM and Nalepa J and Holleman F and Nieuwdorp M and Gumprecht J}, journal={Biomed Pharmacother}, volume={168}, pages={115650}}"}}, {"_id": "11045142", "pmid": 11045142, "title": "[Severe lactic acidosis due to metformin therapy in a patient with contra-indications for metformin].", "journal": "Ned Tijdschr Geneeskd", "authors": ["Houwerzijl EJ", "Snoek WJ", "van Haastert M", "Holman ND"], "date": "2000-09-30T00:00:00Z", "meta_date_publication": "2000 Sep 30", "meta_volume": "144", "meta_issue": "40", "meta_pages": "1923-6", "score": 50060.74, "text_hl": "[Severe @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ due to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy in a @SPECIES_9606 @@@patient@@@ with contra-indications for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@].", "citations": {"NLM": "Houwerzijl EJ, Snoek WJ, van Haastert M, Holman ND. [Severe lactic acidosis due to metformin therapy in a patient with contra-indications for metformin]. Ned Tijdschr Geneeskd. 2000 Sep 30;144(40):1923-6. PMID: 11045142", "BibTeX": "@article{11045142, title={[Severe lactic acidosis due to metformin therapy in a patient with contra-indications for metformin].}, author={Houwerzijl EJ and Snoek WJ and van Haastert M and Holman ND}, journal={Ned Tijdschr Geneeskd}, volume={144}, number={40}, pages={1923-6}}"}}, {"_id": "28738823", "pmid": 28738823, "pmcid": "PMC5525317", "title": "Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer", "journal": "Mol Cancer", "authors": ["Chen K", "Qian W", "Jiang Z", "Cheng L", "Li J", "Sun L", "Zhou C", "Gao L", "Lei M", "Yan B", "Cao J", "Duan W", "Ma Q"], "date": "2017-07-24T00:00:00Z", "doi": "10.1186/s12943-017-0701-0", "meta_date_publication": "2017 Jul 24", "meta_volume": "16", "meta_issue": "1", "meta_pages": "131", "score": 50054.504, "text_hl": "In KPC @SPECIES_10090 @@@mice@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibited @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ growth and the incidence of @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal invasion@@@. ", "citations": {"NLM": "Chen K, Qian W, Jiang Z, Cheng L, Li J, Sun L, Zhou C, Gao L, Lei M, Yan B, Cao J, Duan W, Ma Q. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer Mol Cancer. 2017 Jul 24;16(1):131. PMID: 28738823", "BibTeX": "@article{28738823, title={Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer}, author={Chen K and Qian W and Jiang Z and Cheng L and Li J and Sun L and Zhou C and Gao L and Lei M and Yan B and Cao J and Duan W and Ma Q}, journal={Mol Cancer}, volume={16}, number={1}, pages={131}}"}}, {"_id": "27987248", "pmid": 27987248, "title": "Understanding and overcoming metformin gastrointestinal intolerance.", "journal": "Diabetes Obes Metab", "authors": ["Bonnet F", "Scheen A"], "date": "2017-04-01T00:00:00Z", "doi": "10.1111/dom.12854", "meta_date_publication": "2017 Apr", "meta_volume": "19", "meta_issue": "4", "meta_pages": "473-481", "score": 50053.51, "text_hl": "@DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@GI AEs@@@ typically encountered with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy include @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Flatulence @DISEASE_MESH:D005414 @@@flatulence@@@, @DISEASE_Dyspepsia @DISEASE_MESH:D004415 @@@indigestion@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ and @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal discomfort@@@, with @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ and @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@ being the most common. ", "citations": {"NLM": "Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes Obes Metab. 2017 Apr;19(4):473-481. PMID: 27987248", "BibTeX": "@article{27987248, title={Understanding and overcoming metformin gastrointestinal intolerance.}, author={Bonnet F and Scheen A}, journal={Diabetes Obes Metab}, volume={19}, number={4}, pages={473-481}}"}}, {"_id": "17760733", "pmid": 17760733, "title": "A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.", "journal": "HIV Med", "authors": ["Kohli R", "Shevitz A", "Gorbach S", "Wanke C"], "date": "2007-10-01T00:00:00Z", "doi": "10.1111/j.1468-1293.2007.00488.x", "meta_date_publication": "2007 Oct", "meta_volume": "8", "meta_issue": "7", "meta_pages": "420-6", "score": 50052.516, "text_hl": "METHODS: Forty-eight @DISEASE_HIV_Infections @DISEASE_MESH:D015658 @@@HIV-infected@@@ @SPECIES_9606 @@@men@@@ and @SPECIES_9606 @@@women@@@ with a self-reported @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@increase in abdominal girth@@@ and an abnormal waist-to-hip ratio were randomly assigned in double-blind fashion to receive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1500 mg or placebo daily for 24 weeks. ", "citations": {"NLM": "Kohli R, Shevitz A, Gorbach S, Wanke C. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy. HIV Med. 2007 Oct;8(7):420-6. PMID: 17760733", "BibTeX": "@article{17760733, title={A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.}, author={Kohli R and Shevitz A and Gorbach S and Wanke C}, journal={HIV Med}, volume={8}, number={7}, pages={420-6}}"}}, {"_id": "15991679", "pmid": 15991679, "title": "[Treatment experience with metformin in polycystic ovary syndrome].", "journal": "Orv Hetil", "authors": ["Petrányi G"], "date": "2005-05-22T00:00:00Z", "meta_date_publication": "2005 May 22", "meta_volume": "146", "meta_issue": "21", "meta_pages": "1151-5", "score": 50052.504, "text_hl": "[Treatment experience with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@].", "citations": {"NLM": "Petrányi G. [Treatment experience with metformin in polycystic ovary syndrome]. Orv Hetil. 2005 May 22;146(21):1151-5. PMID: 15991679", "BibTeX": "@article{15991679, title={[Treatment experience with metformin in polycystic ovary syndrome].}, author={Petrányi G}, journal={Orv Hetil}, volume={146}, number={21}, pages={1151-5}}"}}, {"_id": "11045134", "pmid": 11045134, "title": "[Metformin efficacious in poorly controlled diabetes mellitus type 2].", "journal": "Ned Tijdschr Geneeskd", "authors": ["Stades AM", "Holleman F", "Hoekstra JB"], "date": "2000-09-30T00:00:00Z", "meta_date_publication": "2000 Sep 30", "meta_volume": "144", "meta_issue": "40", "meta_pages": "1897-900", "score": 50052.223, "text_hl": "Frequent side effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @<m>DISEASE_Abdominal_Injuries</m> @DISEASE_MESH:D000007 @@@abdominal discomfort@@@ and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@. ", "citations": {"NLM": "Stades AM, Holleman F, Hoekstra JB. [Metformin efficacious in poorly controlled diabetes mellitus type 2]. Ned Tijdschr Geneeskd. 2000 Sep 30;144(40):1897-900. PMID: 11045134", "BibTeX": "@article{11045134, title={[Metformin efficacious in poorly controlled diabetes mellitus type 2].}, author={Stades AM and Holleman F and Hoekstra JB}, journal={Ned Tijdschr Geneeskd}, volume={144}, number={40}, pages={1897-900}}"}}, {"_id": "22933030", "pmid": 22933030, "title": "Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.", "journal": "Breast Cancer Res Treat", "authors": ["Niraula S", "Dowling RJ", "Ennis M", "Chang MC", "Done SJ", "Hood N", "Escallon J", "Leong WL", "McCready DR", "Reedijk M", "Stambolic V", "Goodwin PJ"], "date": "2012-10-01T00:00:00Z", "doi": "10.1007/s10549-012-2223-1", "meta_date_publication": "2012 Oct", "meta_volume": "135", "meta_issue": "3", "meta_pages": "821-30", "score": 50046.34, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in early @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@: a prospective window of opportunity neoadjuvant study.", "citations": {"NLM": "Niraula S, Dowling RJ, Ennis M, Chang MC, Done SJ, Hood N, Escallon J, Leong WL, McCready DR, Reedijk M, Stambolic V, Goodwin PJ. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study. Breast Cancer Res Treat. 2012 Oct;135(3):821-30. PMID: 22933030", "BibTeX": "@article{22933030, title={Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.}, author={Niraula S and Dowling RJ and Ennis M and Chang MC and Done SJ and Hood N and Escallon J and Leong WL and McCready DR and Reedijk M and Stambolic V and Goodwin PJ}, journal={Breast Cancer Res Treat}, volume={135}, number={3}, pages={821-30}}"}}]}